Happy Superbowl Sunday to all who celebrate! Where commercials occasionally interrupted by the World Championship of Football. If you’re reading this from abroad, and if you don’t like the “Football World Championship” phrasing then you are cordially invited to assemble a team of your own to challenge the claim. Super Bowl LX features the Seattle Seahawks versus the New England Patriots at Levi’s Stadium. Bad Bunny headlines the halftime show, with Green Day and Charlie Puth performing pregame. Fans can stream on Peacock or NBC while navigating high ticket prices and mild weather. Continue reading
Tag Archives: Seattle
Super Bowl LX: The Ultimate Guide to the Matchup, Music, and Ads
The “Benito Bowl” and 80-1 Longshots: 5 Ways Super Bowl LX is Rewriting the Playbook
06 Feb. 2026 /Mpelembe Media — The Matchup: Redemption and History Super Bowl LX will take place on February 8, 2026, at Levi’s Stadium in Santa Clara, California. The game features a rematch of Super Bowl XLIX between the Seattle Seahawks (NFC) and the New England Patriots (AFC), both of whom finished the regular season with 14–3 records,. This matchup is unique because both franchises missed the playoffs the previous season, marking a rapid turnaround for both teams. Continue reading
A Divided Pitch: The Rise of “Fortress America” and the Death of the Global Fan
Jan. 9, 2026 /Mpelembe Media/ — The intersection of U.S. immigration policy and the 2026 FIFA World Cup has become a major flashpoint. The feasibility of a boycott and the “ruining” of the game are subjects of intense debate among human rights groups, fans, and governing bodies. Football without fans is like a movie without a soundtrack. You can still follow the plot, and the acting (the skill) is still world-class, but you lose the emotional crescendos that make you jump out of your seat. For a World Cup—an event built on the “unity” of humanity—a lack of fans doesn’t just change the score; it changes the soul of the event. Continue reading
Pfizer Invests $43 Billion to Battle Cancer
Proposed combination enhances Pfizer’s position as a leading company in Oncology
Seagen’s medicines, late-stage development programs and pioneering expertise in Antibody-Drug Conjugates (ADCs) strongly complement Pfizer’s Oncology portfolio
Seagen expected to contribute more than $10 billion in risk-adjusted revenues in 2030
Pfizer and Seagen to hold analyst and investor call at 8 a.m. EDT today
NEW YORK & BOTHELL, Wash.–(BUSINESS WIRE)–Pfizer Inc. (NYSE: PFE) and Seagen Inc. (Nasdaq: SGEN) today announced that they have entered into a definitive merger agreement under which Pfizer will acquire Seagen, a global biotechnology company that discovers, develops and commercializes transformative cancer medicines, for $229 in cash per Seagen share for a total enterprise value of $43 billion. The Boards of Directors of both companies have unanimously approved the transaction. Continue reading
